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after Unprotected Carotid Artery Stent Placement’
J.P.P.M. de Vries*
Department of Vascular Surgery, St. Antonius Hospital, Nieuwegein, Koekoekslaan 1, 3435 EM, The NetherlandsThe article of Grunwald and colleagues in this issue of the
Journal is one in a row of retrospective studies focussing on the
possible association between carotid stent free cell area and clinical
outcome.1 Their main conclusion e different stent designs will not
signiﬁcantly affect the occurrence of adverse clinical events e has
been reached by other researchers as well. Recently, the results of
the Society for Vascular Surgery Vascular Registry (SVS-VR) on
carotid artery stenting (CAS) have been published. Analysis of 4337
CAS procedures demonstrated that both in-hospital results as well
as 30-day clinical outcome were not signiﬁcantly inﬂuenced by
carotid stent cell design.2 Only the non-randomised evaluation of
3179 CAS patients by Bosiers et al. showed favourable results for
closed-cell stents (transient ischaemic attack (TIA)/stroke/death
rate 1.3% vs. 3.4% for open-cell stents, P < 0.02).3 However, this
study has been criticised for possible biases and confounders
(retrospective study, variety of embolic protection devices, etc.).
Review of the current available literature on carotid stent design
and clinical outcome reveals three important gaps.
A The lack of a sufﬁciently powered, randomised controlled
trial between open- and closed-cell stents. In such a trial it will be
valuable to include a detailed analysis of peri-procedural micro-
embolic signals (MESs) during all steps of the CAS procedure by
intra-procedural transcranial Doppler assessment to deﬁne pure
stent-related MES. Post-procedural diffusion weighted magnetic
resonance imaging (DW-MRI) and stent-related MES can be linked
to further reﬁne the inﬂuence of stent design on new brain lesions.
A Physicians have to be aware that carotid stent design is not
just open- versus closed-cell stent conﬁguration. Other technical
aspects including trackability, foreshortening, ﬂexibility and con-
formability are important for successful short-term and long-term
outcome. The ideal carotid stent combines adequate scaffolding of
the vulnerable carotid plaque (protection of plaque fragment
embolisation) with excellent conformability (to appose the arterial
wall) and high radial force/low shear stress (to prevent restenosis).4
It is important to understand that the terms ‘open’ and ‘closed-cell’
reﬂect the bridge connections in between the ring segments andDOI of original article: 10.1016/j.ejvs.2011.10.002.
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Open-cell stents might have smaller cell sizes compared with
closed-cell stents.
A Opposite to the use of sophisticated imaging techniques such
as DW-MRI to extensively evaluate silent (and thus small) brain
lesions post-CAS, a thorough pre-procedural evaluation of the
vulnerability and anatomy of the carotid plaques and arteries is still
underexposed. Imaging of plaque vulnerability and plaque
morphology (for instance with magnetic resonance imaging (MRI)
or virtual histology), degree of arterial wall calciﬁcation and
angulation of the carotid arterial wall are most important for the
process of patientecarotid stent matching.5 For instance in heavily
angulated and vulnerable carotids the ﬂexibility of an open stent is
required, but with small cell sizes to avoid ‘ﬁsh scaling’ in the outer
curvature and minimise the risk of plaque protrusion. Such lesions
might be ideal for the new helically designed stents that combine
ﬂexibility and kink resistance.
In conclusion, device selection during CAS is key for optimal
clinical results. State of the art pre-and per-procedural imaging
combined with thorough knowledge of all stent characteristics is
requested.References
1 Grunwald IQ, Reith W, Karp K, Papanagiotou P, Sievert H, Walter S, et al.
Comparison of stent free cell area and cerebral lesions after unprotected carotid
artery stent placement. Eur J Vasc Endovasc Surg 2012;43:10e4.
2 Jim J, Rubin BG, Landis GS, Kenwood CT, Siami FS, Sicard GA, et al. Society for
vascular surgery vascular registry evaluation of stent cell design on carotid artery
stenting outcomes. J Vasc Surg 2011;54:71e9.
3 Bosiers M, de Donato G, Deloose K, Verbist J, Peeters P, Castriota F, et al. Does free
cell area inﬂuence the outcome in carotid artery stenting? Eur J Vasc Endovasc
Surg 2007;33:135e41. discussion 142e3.
4 Siewiorek GM, Finol EA, Wholey MH. Clinical signiﬁcance and technical assess-
ment of stent cell geometry in carotid artery stenting. J Endovasc Ther
2009;16:178e88.
5 Hart JP, Bosiers M, Deloose K, Uﬂacker R, Schönholz CJ. Impact of stent desing on
the outcome of intervention for carotid bifurcation stenosis. J Cardiovasc Surg
2010;51:799e806.d by Elsevier Ltd. All rights reserved.
